CVE-2021-42025

Description

A vulnerability has been identified in Mendix Applications using Mendix 8 (All versions < V8.18.13), Mendix Applications using Mendix 9 (All versions < V9.6.2). Applications built with affected versions of Mendix Studio Pro do not properly control write access for certain client actions. This could allow authenticated attackers to manipulate the content of System.FileDocument objects in some cases, regardless whether they have write access to it.

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.15%
Vendor Advisory siemens.com
Affected: Siemens Mendix Applications using Mendix 8
Affected: Siemens Mendix Applications using Mendix 9
Published at:
Updated at:

References

Link Tags
https://cert-portal.siemens.com/productcert/pdf/ssa-779699.pdf patch vendor advisory

Frequently Asked Questions

What is the severity of CVE-2021-42025?
CVE-2021-42025 has been scored as a medium severity vulnerability.
How to fix CVE-2021-42025?
To fix CVE-2021-42025, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-42025 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2021-42025 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-42025?
CVE-2021-42025 affects Siemens Mendix Applications using Mendix 8, Siemens Mendix Applications using Mendix 9.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.